Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
17 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Kadcyla“
Suchtreffer
Begriffe & Kennungen
Kadcyla · 4.8 · Laboratory abnormalities
Eintrag öffnenKadcyla · 4.8 · Left ventricular dysfunction Left ventricular dysfunction was reported in 2.2% of patients in MBC clinical stu
Eintrag öffnenKadcyla · 4.8 · Peripheral neuropathy Peripheral neuropathy, mainly as Grade 1 and predominantly sensory, was reported in clin
Eintrag öffnenKadcyla · 4.8 · Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medi
Eintrag öffnenKadcyla · 4.8 · Summary of the safety profile
Eintrag öffnenKadcyla · 4.8 · Table 3 shows pooled data from the overall treatment period in the MBC studies (N = 1871; median number of cyc
Eintrag öffnenKadcyla · 4.8 · Table 4 Laboratory abnormalities observed in patients treated with trastuzumab emtansine in study TDM4370g/BO2
Eintrag öffnenKadcyla · 4.8 · Table 5 Laboratory abnormalities observed in patients treated with trastuzumab emtansine in study BO27938/KATH
Eintrag öffnenKadcyla · 4.8 · Tables 4 and 5 displays laboratory abnormalities observed in patients treated with trastuzumab emtansine in cl
Eintrag öffnenKadcyla · 4.8 · Tabulated list of adverse reactions
Eintrag öffnenKadcyla · 4.8 · The ADRs in 2 611 patients treated with trastuzumab emtansine are presented in Table 3. The ADRs are listed be
Eintrag öffnenKadcyla · 4.8 · The safety of trastuzumab emtansine has been evaluated in 2 611 breast cancer patients in clinical studies. In
Eintrag öffnenKadcyla · 4.8 · Thrombocytopenia Thrombocytopenia or decreased platelet counts were reported in 24.9% of patients in MBC clini
Eintrag öffnenKadcyla · 4.8 · Transaminases increased (AST/ALT) Increase in serum transaminases (Grade 1-4) has been observed during treatme
Eintrag öffnenKadcyla · 4.8 · Trastuzumab emtansine (N = 490) All Parameter Grades (%) Grade 3 (%) Grade 4 (%) Hepatic Increased bilirubin 2
Eintrag öffnenKadcyla · 4.8 · Trastuzumab emtansine (N = 740) Parameter All Grade % Grade 3 (%) Grade 4 (%) Hepatic Increased bilirubin 11 0
Eintrag öffnenKadcyla · 4.8 · the most common serious adverse drug reactions (ADRs) (> 0.5% of patients) were haemorrhage, pyrexia, thromb
Eintrag öffnen